Interpreting protein dose trials in critical illness: a guide for the bedside clinician
Lee-anne Chapple, Julia Bels, Zheng-Yii Lee, Matthew Summers, Suzie Ferrie, Christian Stoppe, Dieter Mesotten, Adam Deane, Marcel C. G. van de Poll, Emma Ridley · 2026
Read Interpreting protein dose trials in critical illness: a guide for the bedside clinician by Lee-anne Chapple, Julia Bels, Zheng-Yii Lee, Matthew Summers, Suzie Ferrie, Christian Stoppe, Dieter Mesotten, Adam Deane, Marcel C. G. van de Poll, Emma Ridley (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13332598.txt.
Description
Lee-anne Chapple and co-authors wrote a 2026 bedside guide to reading the recent big trials of protein dosing in critical illness. Guidelines long urged generous protein to fight the rapid muscle wasting of intensive care, but three international randomized trials covering 5,633 patients have complicated that advice.
The trials found higher protein did not free patients from hospital sooner. It also did not add days alive at home by day 90, and health utility scores over 180 days looked worse with more protein. The guide advises starting low once patients are stable and rising gradually to a ceiling of 1.2 g/kg/day, warning that patients with acute kidney injury may be especially vulnerable to high doses. No safe minimum over a whole stay is known, benefit later in recovery cannot be ruled out, and targets after ICU discharge remain an open question.
Catalog record
| CREATOR | Lee-anne Chapple, Julia Bels, Zheng-Yii Lee, Matthew Summers, Suzie Ferrie, Christian Stoppe, Dieter Mesotten, Adam Deane, Marcel C. G. van de Poll, Emma Ridley |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 56826 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |